286 related articles for article (PubMed ID: 22940701)
1. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
[TBL] [Abstract][Full Text] [Related]
2. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
3. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.
Jing P; Sa N; Liu X; Liu X; Xu W
Exp Mol Pathol; 2016 Feb; 100(1):132-8. PubMed ID: 26704053
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
[TBL] [Abstract][Full Text] [Related]
7. Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.
Qiu H; Tang X; Ma J; Shaverdashvili K; Zhang K; Bedogni B
Mol Cell Biol; 2015 Nov; 35(21):3622-32. PubMed ID: 26283728
[TBL] [Abstract][Full Text] [Related]
8. ADAM10: a new player in breast cancer progression?
Mullooly M; McGowan PM; Kennedy SA; Madden SF; Crown J; O' Donovan N; Duffy MJ
Br J Cancer; 2015 Sep; 113(6):945-51. PubMed ID: 26284334
[TBL] [Abstract][Full Text] [Related]
9. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
10. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
11. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
[TBL] [Abstract][Full Text] [Related]
12. TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization.
Jouannet S; Saint-Pol J; Fernandez L; Nguyen V; Charrin S; Boucheix C; Brou C; Milhiet PE; Rubinstein E
Cell Mol Life Sci; 2016 May; 73(9):1895-915. PubMed ID: 26686862
[TBL] [Abstract][Full Text] [Related]
13. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
14. Increase of ADAM10 level in coronary artery in-stent restenosis segments in diabetic minipigs: high ADAM10 expression promoting growth and migration in human vascular smooth muscle cells via Notch 1 and 3.
Yang K; Lu L; Liu Y; Zhang Q; Pu LJ; Wang LJ; Zhu ZB; Wang YN; Meng H; Zhang XJ; Du R; Chen QJ; Shen WF
PLoS One; 2013; 8(12):e83853. PubMed ID: 24386293
[TBL] [Abstract][Full Text] [Related]
15. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
17. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
[TBL] [Abstract][Full Text] [Related]
18. KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.
Xu Y; Ren H; Jiang J; Wang Q; Wudu M; Zhang Q; Su H; Wang C; Jiang L; Qiu X
Cancer Sci; 2018 Apr; 109(4):1055-1065. PubMed ID: 29451718
[TBL] [Abstract][Full Text] [Related]
19. ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1.
Pan Y; Han C; Wang C; Hu G; Luo C; Gan X; Zhang F; Lu Y; Ding X
J Mol Endocrinol; 2012 Aug; 49(1):21-33. PubMed ID: 22586143
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer].
Jiang X; Zhou JH; Deng ZH; Qu XH; Jiang HY; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):1031-6. PubMed ID: 18182722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
